Elastagen, a clinical-stage medical technology company with an advanced tissue repair platform based on tropoelastin, today announced that it will showcase the latest clinical developments and progress in its pioneering treatments at the Dermatology Summit, January 7, 2018 at The Palace Hotel in San Francisco, and the Biotech Showcase, January 8, 2018 at the Hilton San Francisco Union Square.

Now in development, Elastagen’s tropoelastin tissue repair platform will include breakthrough treatments for acne scars, stretch marks, aesthetic skin repair and wound repair.

In a presentation titled, “Bringing tissue repair and regeneration to medical aesthetics and plastic surgery,” Elastagen Director and CEO Robert Daniels will offer new study data on tropoelastin.

Read the full press release at www.pharmiweb.com